Mirum Pharmaceuticals, Inc. (MIRM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-163,415
-163,415
-135,665
-83,988
-103,270
Depreciation & amortisation
10,829
10,829
3,238
595
623
Deferred income taxes
0
0
-6,580
0
-
Stock-based compensation
35,023
35,023
27,007
23,087
12,554
Change in working capital
-22,640
-22,640
-21,050
16,983
611
Accounts receivable
-43,974
-43,974
-20,727
0
-
Inventory
-4,393
-4,393
-3,448
-495
0
Accounts payable
30,778
30,778
7,639
22,655
3,683
Other working capital
-91,053
-91,053
-120,414
-151,782
-89,300
Other non-cash items
56,544
56,544
15,523
-90,030
335
Net cash provided by operating activities
-70,944
-70,944
-120,136
-132,758
-89,075
Cash flows from investing activities
Investments in property, plant and equipment
-20,109
-20,109
-278
-19,024
-225
Acquisitions, net
-212,762
-212,762
0
0
-
Purchases of investments
-27,329
-27,329
-132,322
-198,029
-74,562
Sales/maturities of investments
153,000
153,000
140,300
157,600
112,661
Other investing activities
-
-
-
108,000
-
Net cash used for investing activities
-107,200
-107,200
7,700
48,547
37,874
Cash flows from financing activities
Common stock issued
216,684
216,684
107,367
6,914
131,871
Dividends paid
-
-
-
0
-
Other financing activities
-195,858
-195,858
-5,552
64,454
49,417
Net cash used provided by (used for) financing activities
336,600
336,600
109,087
73,466
181,288
Net change in cash
158,323
158,323
-3,337
-10,746
130,116
Cash at beginning of period
128,003
128,003
131,340
142,086
11,970
Cash at end of period
286,326
286,326
128,003
131,340
142,086
Free cash flow
Operating cash flow
-70,944
-70,944
-120,136
-132,758
-89,075
Capital expenditure
-20,109
-20,109
-278
-19,024
-225
Free cash flow
-91,053
-91,053
-120,414
-151,782
-89,300
© 2024 Yahoo. All rights reserved.